- Tango plans Phase 3 pancreatic cancer study after combo successWill 2026 be remembered as the year when pancreatic cancer finally became treatable? Following Revolution Medicines’ smashing success at the annual American Society of Clinical Oncology meeting l…Endpoints · 1mo ago↗ source
- Coming SoonNext installments of the biopharma pay series coming soonEndpoints · 1mo ago↗ source
- Biopharma's top-paid CEOs of 2025: 25 making $25M+For the first time in four years, Endpoints News is raising the bar for what it means to be a top-paid CEO. The previous floor of $20 million is no longer rich enough. The biopharma ...Endpoints · 1mo ago↗ source